Casirola D, Kasai S, Gastaldi G, Ferrari G, Matsui K
Institute of Human Physiology, University of Pavia, Italy.
J Nutr Sci Vitaminol (Tokyo). 1994 Aug;40(4):289-301. doi: 10.3177/jnsv.40.289.
The binding of riboflavin to rat small intestinal brush border membrane at equilibrium was formerly shown to have a saturable, specific component, prevailing at the intraluminal physiological concentrations of the vitamin. In this study, the specificity of riboflavin binding to rat small intestinal brush border vesicles was further investigated using structural analogues of riboflavin. The vesicles, prepared by Ca(2+)-precipitation, were incubated at 25 degrees C, for 20 min, in the presence of [3H]-riboflavin at physiological intraluminal concentrations for rat, and each analogue, at appropriate concentrations. Three groups of analogues were used, that were derived from the riboflavin molecule by modifying one of the following positions: the ribityl side chain, position 3, and position 8 of the isoalloxazine moiety. Group specificity was assessed by determining the inhibition potency of each analogue on the saturable component of riboflavin binding to the vesicles. Inhibition constants were calculated, according to Dixon, for lumiflavin, lumichrome, and for analogues substituted at position 8. Specific riboflavin binding was inhibited competitively by most of the analogues used. Substitutions at the ribityl side chain or at position 3 of the isoalloxazine moiety reduced the inhibition power. Substitutions at position 8 enhanced the inhibition power in direct proportion to the bulk of the substituents. We conclude that the ribityl side-chain and the NH group at position 3 are essential for recognition by the specific binding sites, whereas the methyl group at position 8 is important but not essential. The analogues that bind to specific membrane sites for riboflavin share specificity requirements with many riboflavin binding proteins, and are also good substrates for the intracellular phosphorylating enzyme flavokinase. Thus, the riboflavin-binding component in the membrane is likely to be a protein with high specificity. Cellular internalization of the membrane bound vitamin is probably achieved by phosphorylation of the vitamin bound to the inner side of the membrane.
以前的研究表明,核黄素在平衡状态下与大鼠小肠刷状缘膜的结合具有可饱和的特异性成分,在该维生素的肠腔内生理浓度下占主导地位。在本研究中,使用核黄素的结构类似物进一步研究了核黄素与大鼠小肠刷状缘小泡结合的特异性。通过Ca(2+)沉淀制备的小泡在25℃下,于大鼠肠腔内生理浓度的[3H] - 核黄素以及每种适当浓度的类似物存在下孵育20分钟。使用了三组类似物,它们是通过修饰核黄素分子的以下位置之一衍生而来的:核糖醇侧链、位置3以及异咯嗪部分的位置8。通过确定每种类似物对核黄素与小泡结合的可饱和成分的抑制效力来评估组特异性。根据狄克逊法计算了荧光黄素、光色素以及在位置8处被取代的类似物的抑制常数。所使用的大多数类似物竞争性抑制特异性核黄素结合。在核糖醇侧链或异咯嗪部分的位置3处进行取代会降低抑制能力。在位置8处进行取代会使抑制能力与取代基的体积成正比增强。我们得出结论,核糖醇侧链和位置3处的NH基团对于特异性结合位点的识别至关重要,而位置8处的甲基很重要但并非必不可少。与核黄素特异性膜位点结合的类似物与许多核黄素结合蛋白具有共同的特异性要求,并且也是细胞内磷酸化酶黄素激酶的良好底物。因此,膜中的核黄素结合成分可能是一种具有高特异性的蛋白质。膜结合维生素的细胞内化可能是通过与膜内侧结合的维生素的磷酸化来实现的。